RCTs
13
3
3
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.7%
1 terminated/withdrawn out of 13 trials
88.9%
+2.4% vs industry average
8%
1 trials in Phase 3/4
38%
3 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Lomatuell Pro® Versus UrgoTul® in the Management of Acute Wounds
Role: collaborator
Initial Standardized Global Review in Axial Spondyloarthritis
Role: collaborator
Clinical Investigation Evaluating the Use of NETSmart Solution , Incorporated to NETSoins Software, in the Care and Support of Elderly People Living in Nursing Homes
Role: collaborator
Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease
Role: collaborator
Pilot Clinical Investigation Evaluating the Safety and Performance of RGn550 in Treating Sportspeople Suffering From Acute Concussion Syndrome
Role: collaborator
Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
Role: collaborator
Lumbar Belt Benefit Compared to the Usual Care in the Treatment of Non-specific Low Back Pain
Role: collaborator
Interventional Clinical Trial Comparing Kerecis Omega3 Wound Versus SOC in Diabetic Foot Wounds
Role: collaborator
Safety Study of AZT-04 for Cosmetic Use
Role: collaborator
Treat to Target Trial in Axial Spondylo Arthritis : The TICOSPA (Tight Control in Spondyloarthritis)
Role: collaborator
PREDICT-SpA - French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and - Experienced Patients
Role: collaborator
The Sorbact® Antimicrobial Dressing in the Holistic Wound Management Of Diabetic Foot ulCers (Phase III Study)
Role: collaborator
Sensitivity of Echography in Arthritis
Role: collaborator
All 13 trials loaded